Notification of Major Holdings1. Details of issuer | Name: | RHÖN-KLINIKUM Aktiengesellschaft |
| Street: | Salzburger Leite 1 |
| Postal code: | 97616 |
| City: | Bad Neustadt a.d.SaaleGermany |
| Legal Entity Identifier (LEI): | 529900MVGMIVUDQY9E20 |
2. Reason for notification | | Acquisition/disposal of shares with voting rights |
| X | Acquisition/disposal of instruments |
| | Change of breakdown of voting rights |
| | Other reason: |
3. Details of person subject to the notification obligation | Natural person (first name, surname): Dr. Bernard große BroermannDate of birth: 20 Nov 1943 |
4. Names of shareholder(s)holding directly 3% or more voting rights, if different from 3.
| Asklepios Kliniken GmbH & Co. KGaA |
5. Date on which threshold was crossed or reached:6. Total positions | | % of voting rights attached to shares (total of 7.a.) | % of voting rights through instruments (total of 7.b.1 + 7.b.2) | Total of both in % (7.a. + 7.b.) | Total number of voting rights pursuant to Sec. 41 WpHG |
| New | 28.99 % | 48.69 % | 48.99 % | 66962470 |
| Previous notification | 25.10 % | n/a % | 25.10 % | / |
7. Details on total positionsa. Voting rights attached to shares (Sec. 33, 34 WpHG) | ISIN | Absolute | In % |
| | Direct (Sec. 33 WpHG) | Indirect (Sec. 34 WpHG) | Direct (Sec. 33 WpHG) | Indirect (Sec. 34 WpHG) |
| DE0007042301 | 360 | 19415354 | 0.0005 % | 28.99 % |
| Total | 19415714 | 28.99 % |
b.1. Instruments according to Sec. 38 (1) no. 1 WpHG | Type of instrument | Expiration or maturity date | Exercise or conversion period | Voting rights absolute | Voting rights in % |
| | | | % |
| | | Total | | % |
b.2. Instruments according to Sec. 38 (1) no. 2 WpHG | Type of instrument | Expiration or maturity date | Exercise or conversion period | Cash or physical settlement | Voting rights absolute | Voting rights in % |
| right to transfer shares under share purchase agreement subject to a condition precedent | | | | 8294407 | 12.39 % |
| contribution obligation subject to a condition precedent under joint venture agreement | | | | 32601606 | 48.69 % |
| | | | Total | 32601606 | 48.69 % |
8. Information in relation to the person subject to the notification obligation | | Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.). |
| X | Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity: |
| Name | % of voting rights (if at least 3% or more) | % of voting rights through instruments (if at least 5% or more) | Total of both (if at least 5% or more) |
| Dr. Bernard große Broermann | % | % | % |
| Asklepios Kliniken Management GmbH | % | % | % |
| Asklepios Kliniken GmbH & Co. KGaA | 28.69 % | % | 28.69 % |
| AMR Holding GmbH i.G. | % | 48.69 % | 48.69 % |
| | | | |
| Dr. Bernard große Broermann | % | % | % |
| Broermann Holding GmbH | % | % | % |
| Asklepios Kliniken GmbH & Co. KGaA | 28.69 % | % | 28.69 % |
| AMR Holding GmbH i.G. | % | 48.69 % | 48.69 % |
9. In case of proxy voting according to Sec. 34 para. 3 WpHG(only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG)Date of general meeting: Holding total positions after general meeting (6.) after annual general meeting:
| Proportion of voting rights | Proportion of instruments | Total of both |
| % | % | % |
10. Other explanatory remarks: | On 28 February 2020 Asklepios Kliniken GmbH & Co. KGaA ("Asklepios") concluded a purchase agreement, subject to a condition precedent, with Eugen and Ingeborg Münch for the acquisition of a 12.39% stake in RHÖN-KLINIKUM AG ("RHÖN").Asklepios has agreed in a joint venture agreement dated 28 February 2020, subject to a condition precedent, to contribute, after closing of the purchase agreement, Asklepios' stake in RHÖN (as of 28 February 2020, taking the share purchase agreement into account: 41.07%) to AMR Holding GmbH i.G. ("AMR"). As this stake includes the 28.69% already held by Asklepios, voting rights and instruments are not aggregated in this amount. In addition, HCM SE has agreed to contribute a 7.61% stake in RHÖN to AMR subject to a condition precedent. |
Date
